These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6950660)

  • 1. Busulfan, antimetabolites, radiotherapy, and cost of treatment in chronic myelocytic leukemia. A non-controlled, non-randomized monocenter study with historical controls.
    Ogier C; Reizenstein P
    Acta Med Scand; 1981; 210(5):409-13. PubMed ID: 6950660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 13-years remission in chronic myelocytic leukemia after a single course of busulfan.
    Weinberger A; Benjamin D; Douer D; Barabash G; Djaldetti M; Pinkhas J
    Acta Haematol; 1978; 59(6):354-9. PubMed ID: 97894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose intensification in acute myeloid leukaemia: greater effectiveness at lower cost. Principal report of the Medical Research Council's AML9 study. MRC Leukaemia in Adults Working Party.
    Rees JK; Gray RG; Wheatley K
    Br J Haematol; 1996 Jul; 94(1):89-98. PubMed ID: 8757514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of acute myelocytic leukemia. Daunomycin contrasted with a combination of cytosine arabinoside and 6-thioguanine.
    Poth JL; Johnson PK; George RP; Schrier SL
    Calif Med; 1972 Dec; 117(6):1-11. PubMed ID: 4508367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preliminary studies on the effectiveness of the association cytosine-arabinoside, thioguanine, hydroxyureas in the treatment of blastic crisis in chronic myeloid leukemia].
    Papa G; Amadori S; Monarca B; Alimena G; Esposito A; Mandelli F
    Haematologica; 1972; 58(9):597-600. PubMed ID: 4206235
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemia.
    Carey RW; Ribas-Mundo M; Ellison RR; Glidewell O; Lee ST; Cuttner J; Levy RN; Silver R; Blom J; Haurani F; Spurr CL; Harley JB; Kyle R; Moon JH; Eagan RT; Holland JH
    Cancer; 1975 Nov; 36(5):1560-6. PubMed ID: 1059499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic studies during remission of blastic crisis in a patient with chronic myelocytic leukaemia.
    Srodes CH; Hyde EF; Pan SF; Chervenick PA; Boggs DR
    Scand J Haematol; 1973; 10(2):130-5. PubMed ID: 4517256
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical conference: Splenic radiotherapy in myeloid leukemia; comparative study of chemotherapy].
    Revol L; Viala JJ; Guyon JM
    Nouv Rev Fr Hematol; 1975; 15(2):245-9. PubMed ID: 126434
    [No Abstract]   [Full Text] [Related]  

  • 9. Remission maintenance for acute nonlymphocytic leukemia: cytosine arabinoside plus 6-thioguanine versus a sequence of drug regimens.
    Presant CA; Berger NA; Klahr C; Phillips GL
    Cancer; 1980 Jul; 46(1):22-8. PubMed ID: 6930320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chromosome analysis and TdT determination: important prognostic parameters of blastic crises in chronic myelocytic leukemia].
    Schwarzmeier JD; Haas O; Paietta E; Fischer P
    Wien Klin Wochenschr; 1982 Oct; 94(19):514-20. PubMed ID: 6760560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splenic irradiation in chronic myeloid leukemia.
    Hukku S; Baboo HA; Venkataratnam S; Vidyasagar MS; Patel NL
    Acta Radiol Oncol; 1983; 22(1):9-12. PubMed ID: 6305140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined plateletpheresis and cytotoxic chemotherapy for symptomatic thrombocytosis in myeloproliferative disorders.
    Baron BW; Mick R; Baron JM
    Cancer; 1993 Aug; 72(4):1209-18. PubMed ID: 8339212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of blastic crisis of chronic myeloid leukaemia with thioguanine, rubidomycin, ARA C and prednisone (TRAP regimen).
    Resegotti L; Falda M; Rossi M; Infelise VE
    Panminerva Med; 1973 Sep; 15(9):275-7. PubMed ID: 4533778
    [No Abstract]   [Full Text] [Related]  

  • 14. Dibromomannitol in the treatment of chronic granulocytic leukemia: a prospective randomized comparison with busulfan.
    Canellos GP; Young RC; Neiman PE; DeVita VT
    Blood; 1975 Feb; 45(2):197-203. PubMed ID: 1054609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic bone marrow transplantation in high-risk myeloid disorders using busulfan, cytosine arabinoside and cyclophosphamide (BAC).
    Ratanatharathorn V; Karanes C; Lum LG; Uberti J; Dan ME; de Planque MM; Schultz KR; Cronin S; Leisz MC; Mohamed A
    Bone Marrow Transplant; 1992 Jan; 9(1):49-55. PubMed ID: 1543949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of relationship between in vitro cell measurements and response to busulfan in chronic myelocytic leukemia.
    Kirshner J; Preisler HD; Raza A
    Am J Hematol; 1985 Feb; 18(2):191-200. PubMed ID: 3855599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of cytostatic and radiologic treatment of chronic myelocytic leukemia (analysis of 11 cases)].
    Maurice PA
    Rev Med Suisse Romande; 1970 Jun; 90(6):521-32. PubMed ID: 5293581
    [No Abstract]   [Full Text] [Related]  

  • 18. [Letter: Comparative study of busulfan and of the combination of busulfan with splenic radiotherapy in the treatment of chronic myeloid leukemias].
    Messerschmitt J; Colonna P; Hamladji RM; Belkhodja A; Taleb A
    Nouv Presse Med; 1975 Nov; 4(39):2812. PubMed ID: 1105426
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic myelogenous leukemia: a clinical and experimental evaluation of splenectomy and intensive chemotherapy.
    Brodsky I; Fuscaldo KE; Kahn SB; Conroy JF; Lamping CG
    Ser Haematol; 1975; 8(4):143-56. PubMed ID: 798283
    [No Abstract]   [Full Text] [Related]  

  • 20. [Progress in the treatment of acute leukemias].
    Cavalli F
    Schweiz Med Wochenschr; 1978 Aug; 108(32):1233-8. PubMed ID: 276922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.